Výsledky vyhledávání

Abstract P5-20-10: Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer: Preliminary Results of a Phase II Trial of the Sarah Cannon Research Institute

Autor: C Handricks, Mythili Shastry, Patrick S. Ward, N. W. Peacock, William N. Harwin, R Saez, T Chirwa, D. A. Yardley, Brooke R. Daniel, G Kannarkat

Publikováno v: Cancer Research. 72:P5-20

Background: Triple-negative breast cancer (TNBC) is a poor prognosis subtype with treatment limited to chemotherapy. Over expression of epidermal growth factor receptor (EGFR) occurs in up to 70% of TNBC providing a potential targetable receptor for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ce3f0d5a029efd9e66d5df7ec869f64
https://doi.org/10.1158/0008-5472.sabcs12-p5-20-10

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání